findmyKOL

Pinak Acharya, MD

Basic profile

The Wistar Institute

ORCIDNone on fileNPI↗
✓ Full record
RegionDoylestown, PA · NortheastSpecialtyPulmonary DiseaseFocusRespiratory
Active KOLfindmyKOL type: RegionalLatest publication2008Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Pinak Acharya is a Respiratory physician affiliated with The Wistar Institute. OpenAlex indexes 6 publications with 429 citations (h-index 5).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
6publications

Distinct works indexed by OpenAlex.

429citations

Total citations across indexed works.

5h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
46companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1980 South Easton Road Suite 230
Bucks County Medical Associates
Doylestown, PA 18901

Telephone

215-348-1310

Registry record last updated 1 Nov 2019.

View the NPPES registry record

Industry payments

46 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Respiratory

    77.8%
    Corticosteroid42.3%
    Trelegy Ellipta34%Breo Ellipta22%Arnuity Ellipta13%Symbicort11%Budesonide-Formoterol Fumarate7%Breztri Aerosphere5%Fluticasone Propionate3%Qvar Redihaler2%Fluticasone Propionate Hfa2%Pulmicort Flexhaler1%Breyna1%
    Part D<11 patients
    beta2-Adrenergic Agonist16%
    Albuterol Sulfate Hfa88%Ventolin Hfa12%
    Part D≥119 patients

    + 3 more classes in this area

  • Metabolism & gastrointestinal

    13%
    Corticosteroid9.4%
    Prednisone100%
    Part D≥78 patients
    Proton pump inhibitor1.9%
    Omeprazole62%Pantoprazole Sodium38%
    Part D<11 patients

    + 1 more class in this area

  • Anti-infectives

    4%
    Macrolide Antimicrobial4%
    Azithromycin100%
    Part D≥35 patients
Where care is delivered (Part B)14.8% facility · 85.2% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”